TeamMS
  • MS Education
    • What is MS?
    • MS News Tips
  • How To Get Involved
    • Join TeamMS
    • Our Supporters
    • Show Your Support
    • Share Your Story
  • About Team MS
    • Who is TeamMS?
    • Team MS in Action
    • Contact
  • COVID-19 Information

Have we been looking at Multiple Sclerosis all wrong?

1/27/2012

0 Comments

 
The following article was penned by Tim Barribeau, it looks at what causes and what might be a treatment for MS. Please keep in mind that there is a long way to go here on this proposed idea but it does offer hope that people are still looking.

Multiple sclerosis is a confusing disease. Widely regarded as an autoimmune problem, it affects millions of sufferers, and we still don't have a complete grasp of what causes it. Part of this problem is due to the fact that every time we find something that seems to be a factor in how it works, that factor doesn't seem universal. But now there's a new theory of MS that could lead to a radically different treatment for the disease.

Read More
0 Comments

Scientists unveil first MS stem cell model

12/22/2011

0 Comments

 
The following article was written by Julia Medew and published in the The Sydney Morning Herald. ​

Australian researchers have developed the world's first stem cell model of multiple sclerosis, opening up new ways to study the disease and test treatments.

The deputy director of Monash University's immunology and stem cell laboratory, Claude Bernard, said he and his colleagues had used skin cells from MS sufferers to create induced pluripotent stem cells that have the capacity to become brain cells targeted by the disease.

Read More
0 Comments

A Busy Week for Multiple Sclerosis News

9/25/2010

1 Comment

 
This article was written by taken from OneMedPlace. 

It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate. On Wednesday, Novartis’ Gilenya became the first oral drug in the U.S. approved to treat the chronic inflammatory disease. Gilenya is approved to reduce relapses and delay disability progression in MS patients. 

Read More
1 Comment

FDA approves drug for multiple sclerosis

1/22/2010

2 Comments

 
This story was written by Georgiann Caruso and was curated from CNN Medical News.

The second-to-last time EJ Levy was at Disney World, she used a scooter to navigate the enormous park. Her legs were weak and she suffered from foot drop caused by multiple sclerosis. That was 4½ years ago. On her most recent trip, a few months ago, Levy walked the entire time, thanks in part to a drug approved by the FDA on Friday. The FDA says the drug, Ampyra (generic name dalfampridine, formerly known as fampridine), is the first MS therapy that is taken orally and the first of its kind to receive FDA approval. It is designed help people with any type of MS improve their walking speed. ​

Read More
2 Comments

Wisconsin women shows the need for activity when living with MS

1/1/2010

0 Comments

 
This story was curated from Lori Schneider;s website Empowerment Through Adventure. A perfect example of the Team MS mission. 
​
A series on climbing Mount Everest airing on the Discovery Channel is giving a Bayfield woman flashbacks. Mike Simonson reports from Superior.

Lori Schneider became the first person with multiple sclerosis to climb to the top of Mount Everest. She did that in May.
​

"It's still surreal in my mind that I was ever up there. When I was watching the Mount Everest shows, it hit me. Did I really do that? (laughs)"

Read More
0 Comments
<<Previous

    Categories

    All
    MS News
    MS Tips

    RSS Feed

LEarn more

What is MS?

Join TeamMS
​

Bonneville Speed Week 2017

Company

Who is TeamMS?
Team MS in Action

Support

Contact
© COPYRIGHT 2017. ALL RIGHTS RESERVED Team Ms® is a registered trademark  
  • MS Education
    • What is MS?
    • MS News Tips
  • How To Get Involved
    • Join TeamMS
    • Our Supporters
    • Show Your Support
    • Share Your Story
  • About Team MS
    • Who is TeamMS?
    • Team MS in Action
    • Contact
  • COVID-19 Information